View:
Download DOC
Download PDF
Download XLS

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2019

--------------

 

Commission File Number: 001-34563

----------

 

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

--------------

18/F, Tower A, Global Trade Center

36 North Third Ring Road East, Dongcheng District

Beijing 100013

People’s Republic of China

(Address of principal executive office)

--------------

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x            Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ________

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ________

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  CONCORD MEDICAL SERVICES HOLDINGS LIMITED
   
   
  By: /s/ Jianyu Yang
  Name: Jianyu Yang
  Title: Chairman and Chief Executive Officer

 

 

Date: November 29, 2019

 

 

 

 

Exhibit Index

 

Exhibit No.  Description
99.1  Press Release
99.2  Notice of Annual General Meeting
99.3  Form of Shareholder Proxy

 

 

Exhibit 99.1

 

Concord Medical Schedules 2019 Annual Meeting of Shareholders

 

BEIJING, November 28, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2019 annual general meeting of shareholders on December 27, 2019, at 10:00 a.m. (Beijing Time). The meeting will be held at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, China. The shareholder record date is December 9, 2019. No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will be convened for shareholders who are entitled to vote to discuss Company affairs with management. Concord Medical’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission, containing the Company’s audited financial statements for the financial year ended December 31, 2018, is available in the Investor Relations section of the Company’s website at http://ir.ccm.cn. The Form 20-F is also available on the SEC’s website at http://www.sec.gov.

 

About Concord Medical

 

Concord Medical Services Holdings Limited is a specialty hospital management group, including premium cancer hospitals and international hospitals with multi-disciplinary treatment featuring proton therapy, as well as secondary specialty cancer hospitals and independent medical institutions, and an operator of the network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2019, the Company operated a network of 30 centers based in 20 hospitals, spanning over 20 cities across 13 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.ccm.cn.

 

For more information, please contact:

 

Concord Medical Services Holdings Limited

Mr. Edward Zhang(Chinese and English)

+86 10 5903 6688 (ext. 608)

zhongchen.zhang@ccm.cn

 

 

Exhibit 99.2

 

Concord Medical Services Holdings Limited

(the "Company")

 

NOTICE OF Annual GENERAL MEETING

 

 

NOTICE is hereby given that an annual general meeting of the Company (the “Meeting”) will be held on December 27, 2019 at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for shareholder approval at the Meeting. Instead, the Meeting will be convened for shareholders who are entitled to vote to discuss Company affairs with management.

 

The board of directors of the Company has fixed the close of business on December 9, 2019 as the record date (the “Record Date”) for determining the shareholders entitled to receive notice of the Meeting or any adjournment thereof.

 

Holders of record of the Company’s ordinary shares at the close of business on the Record Date are entitled to attend the AGM and any adjournment or postponement thereof.

 

A shareholder entitled to attend the Meeting is entitled to appoint a proxy to attend on his/her behalf. A proxy need not be a shareholder of the Company. A form of proxy is attached.

 

To be valid, the form of proxy must be duly completed, signed and delivered (in the case of a corporation, the form of proxy should be given under such shareholder’s common seal or under the hand of an officer, attorney or other person duly authorised in writing to sign the same) to 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China for the attention of director Yang Jianyu or emailed to zhongchen.zhang@ccm.cn no later than the time for holding the Meeting or the adjourned meeting at which the proxy is to be used.

 

Shareholders and holders of American depositary shares of the Company may obtain a copy of the Company’s annual report on Form 20-F, containing the Company’s audited financial statements for the financial year ended December 31, 2018, from the Investor Relations section of the Company’s website at http://ir.ccm.cn or the website of the Securities and Exchange Commission at http://www.sec.gov.

 

By the Order of the Board of Directors,
CONCORD MEDICAL SERVICES HOLDINGS LIMITED

 

/s/ Jianyu Yang 
Chairman 
  
Date: 11/28/2019 

 

 

Exhibit 99.3

 

Concord Medical Services Holdings Limited

(the “Company”)

 

 

P R O X Y

 

 

I/We* ............................................................... (name) of ........................................................................................................................ (address), the holder of ............................................................ (number) Class A ordinary shares and ............................................................ (number) Class B ordinary shares in the Company, hereby appoint .............................................................. (name) of ........................................................................................................................ (address) and/or* failing him/her*, .............................................................. (name) of ........................................................................................................................ (address), or failing him/her/them*, the Chairman of the meeting as my/our proxy/proxies* to attend on my/our* behalf at the annual general meeting of the Company to be held on the 27th December 2019 at 10:00 a.m. (Beijing time) at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China, and at any adjournment thereof.

 

 

*Please delete as appropriate.

 

Date: __________________________

 

Signed by or on behalf of the above named

 

 

____________________________________

Name:

 

 

 

 

NOTES

1.To be effective, this form of proxy must be duly completed, signed and delivered to 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China for the attention of director Yang Jianyu or emailed to zhongchen.zhang@ccm.cn no later than the time for holding the Meeting or the adjourned meeting at which the proxy is to be used.

 

2.Any alterations made to this form of proxy should be initialled.

 

3.In the case of a corporation, this instruction should be given under its Common Seal or under the hand of an officer, attorney or other person duly authorised in writing to sign the same.